laitimes

Small K Broadcast Morning Report | Shanghai will promote the listing of high-tech enterprises on the Science and Technology Innovation Board The United States pushed the construction plan of 5 billion US dollars of charging stations

author:Finance Associated Press

"Science and Technology Innovation Board Daily" (Shanghai, Zhou Xinyue) news, today's science and technology innovation board morning report main contents are: the Ministry of Commerce will vigorously develop digital trade, build a digital trade demonstration zone; eight departments to promote the application of waste power batteries in the field of power backup, charging and replacement and other fields of safe ladder; SMIC's fourth quarter revenue of 1.58 billion US dollars, an increase of 61% year-on-year.

Xiao K, the anchor of "Science and Technology Innovation Board Daily", broadcasts it for you.

【Market Dynamics】

Shanghai: Promote the listing of high-tech enterprises on the Science and Technology Innovation Board

The 2022 Shanghai State-owned Assets and State-owned Enterprises Reform and Development and Party Building Work Video Conference was held on February 10. In 2022, Shanghai will deepen the reform of mixed ownership, promote the listing of high-tech enterprises on the Science and Technology Innovation Board, and promote the introduction of strategic investors or joint restructuring of a number of second- and third-level enterprises. Improve the incentive and constraint mechanism, and promote a number of listed companies and scientific and technological innovation enterprises to implement equity incentives.

The U.S. launches a $5 billion electric vehicle charging station construction program

The Biden administration has detailed how it will allocate $5 billion over five years to states to build thousands of electric vehicle charging stations. The Biden administration has pledged that half of the cars sold in the U.S. will be electric or plug-in hybrids by 2030. Under the U.S. National Electric Vehicle Infrastructure Plan, U.S. states must submit their EV infrastructure deployment plans to the Joint Office of Energy and Transportation by August 1.

Ministry of Commerce: Vigorously develop digital trade to build a digital trade demonstration zone

Gao Feng, spokesman of the Ministry of Commerce, said that the Ministry of Commerce will study and promote the introduction of a number of new policies and measures this year, vigorously develop digital trade, build a digital trade demonstration zone, and promote the innovation of science and technology and system.

Eight departments: promote the safe ladder application of waste power batteries in the fields of power backup, charging and replacement

Eight departments, including the Ministry of Industry and Information Technology, issued an implementation plan for accelerating the comprehensive utilization of industrial resources. The plan proposes to improve the management system and strengthen the traceability management of the whole life cycle of new energy vehicle power batteries. Promote the application of waste power batteries in the fields of power backup, charging and replacement.

Twitter's fourth-quarter revenue of $1.57 billion will buy back $4 billion of its shares

Twitter's fourth-quarter revenue was $1.57 billion, up 22% year-over-year. Net income was $182 million. Twitter revenue for the entire 2021 period was $5.08 billion, up 37% year-over-year. Net loss was $221 million. In addition, Twitter's board of directors has approved a new $4 billion share repurchase program, which takes effect immediately and replaces the previously approved $2 billion plan that began in 2020 (about $819 million has not yet been repurchased).

【Company View】

SMIC's fourth-quarter revenue of $1.58 billion increased 61% year-over-year

SMIC announced in Hong Kong that its net profit for the fourth quarter of 2021 was US$533.8 million, an estimated US$353.3 million, an increase of 107.7% year-on-year, and fourth-quarter revenue was US$1.58 billion, an estimated US$1.59 billion, an increase of 11.6% sequentially and 61.1% year-on-year. In addition, SMIC said that the company expects the annual sales revenue growth rate in 2022 to be better than the average of the generation industry, the gross profit margin is higher than the company's 2021 level, and the capital expenditure is expected to be about $5 billion.

WuXi AppTec: The company found no other media reports or market rumors that required clarification or response

WuXi AppTec announced that neither the company nor its subsidiaries were included in the U.S. Department of Commerce's Unverified List. For details, please refer to the previous Clarification Announcement. After the Company's self-examination, as of the date of disclosure of this announcement, the Company has not found any other media reports or market rumors that need clarification or response.

China Mobile Hong Kong Stocks: Repurchased shares at approximately HK$422 million

China Mobile announced on the Hong Kong Stock Exchange that it repurchased 7.3035 million shares at a price of HK$56.65 to HK$58.15 per share on February 10, costing about HK$422 million.

Yahuilong: The novel coronavirus antigen detection kit has been approved and supplied by the Japanese PMDA

Yahuilong announced that the novel coronavirus antigen detection kit of the company's Japanese partner, the Institute of Medical Biology Co., Ltd. (hereinafter referred to as "MBL"), has obtained the "Production and Sales License for In Vitro Diagnostic Products" (i.e., Japan PMDA Certification) issued by the Japanese PMDA on February 10.

Medici: It is planned to raise no more than 2.16 billion yuan for projects such as pharmaceutical research and development innovation industry bases

Medici announced that it plans to raise no more than 2.16 billion yuan for the Medici Northwest Shanghai Biomedical R&D and Innovation Industrial Base Project, the laboratory expansion project of the drug discovery and pharmaceutical research and declaration platform and supplementary working capital.

Fangyuan shares: it is proposed to issue convertible bonds of not more than 660 million yuan for projects with an annual output of 50,000 tons of high-end ternary lithium battery precursors

Fangyuan shares announced that it intends to issue convertible bonds to raise no more than 660 million yuan for the annual output of 50,000 tons of high-end ternary lithium battery precursors (NCA, NCM) and 10,000 tons of battery lithium hydroxide project.

【Frontiers of Science and Technology】

Ultrasound successfully controlled mammalian brain cells for the first time

Scientists at the Salk Institute in the United States published a paper in the journal Nature Communications published on the 9th that they genetically edited human cells and brain cells in live mice in the dish, adding the channel protein TRPA1 to them, activating these cells with ultrasound for the first time. This new approach paves the way for the development of in vitro pacemakers and insulin pumps for noninvasive deep brain stimulation, promising better treatments for epilepsy, heart disease and other diseases.

The world's first biological agent for the treatment of lupus nephritis was approved in China

GlaxoSmithKline (GSK) announced that the world's first biologic agent for the treatment of lupus nephritis has been approved by the National Drug Administration (NMPA) for use in adult patients with active lupus nephritis (LN) in combination with conventional treatment. It is reported that the approval of the lupus nephritis indications makes beliyuzumab the first and only biological agent covering systemic lupus erythematosus and lupus nephritis indications in China.

Combinations of antiviral drugs are highly effective in responding to COVID-19

American scientists published a paper in the latest issue of the journal Nature that the nucleotide drug brequinar, which is currently undergoing clinical trials against the new crown virus, is combined with remdesivir (remdesivir) or the new crown oral drug monapiravir (molnupiravir), which can inhibit the new crown virus in human respiratory cells and mice, and the combination of drugs is more effective than the use alone.

Read on